Deborah A Hall Selected Research

Albumins

2/2022

Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deborah A Hall Research Topics

Disease

30	Tinnitus 01/2022 - 07/2011
16	Fragile X Tremor Ataxia Syndrome 04/2024 - 11/2005
12	Parkinson Disease (Parkinson's Disease) 11/2023 - 11/2012
5	Tremor (Tremors) 04/2024 - 10/2006
4	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024 - 12/2019
4	Hearing Loss (Hearing Impairment) 01/2023 - 07/2015
4	Movement Disorders (Movement Disorder) 01/2023 - 10/2006
4	Parkinsonian Disorders (Parkinsonism) 01/2022 - 10/2006
3	Deafness (Deaf Mutism) 09/2022 - 03/2020
2	Sensorineural Hearing Loss 01/2023 - 03/2020
2	Inflammation (Inflammations) 01/2023 - 01/2022
2	Neoplasms (Cancer) 01/2021 - 01/2018
2	Hypokinesia (Bradykinesia) 10/2020 - 04/2014
2	Cognitive Dysfunction 01/2020 - 10/2006
2	Hypertension (High Blood Pressure) 01/2019 - 01/2018
2	Fragile X Syndrome (Martin Bell Syndrome) 01/2018 - 05/2013
2	Intellectual Disability (Idiocy) 01/2016 - 08/2011
1	Cerebellar Ataxia (Dysmetria) 04/2024
1	Otitis Media 01/2023
1	Essential Tremor (Essential Tremors) 01/2023
1	Acute-Phase Reaction 02/2022
1	Synucleinopathies 01/2022
1	Kidney Diseases (Kidney Disease) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Multiple System Atrophy 01/2022
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 11/2021
1	Dyskinesias (Dyskinesia) 11/2021
1	Vertigo (Positional Vertigo) 01/2021
1	Benign Paroxysmal Positional Vertigo 01/2021
1	Dizziness (Lightheadedness) 01/2021
1	Diabetes Mellitus 01/2019
1	Hyperlipidemias (Hyperlipidemia) 01/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 12/2018
1	Ear Diseases (Disease, Ear) 03/2018
1	Hidden Hearing Loss 03/2018

Drug/Important Bio-Agent (IBA)

6	Messenger RNA (mRNA)IBA 01/2018 - 11/2005
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2016
3	Silver Sulfadiazine (SSD)FDA LinkGeneric 09/2022 - 03/2020
3	Proteins (Proteins, Gene)FDA Link 02/2022 - 04/2004
2	messenger ribonucleoproteinIBA 04/2024 - 01/2023
2	Antipsychotic Agents (Antipsychotics)IBA 01/2023 - 01/2009
2	PlatinumIBA 01/2023 - 01/2018
2	ProteomeIBA 02/2022 - 02/2022
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 01/2021
2	5' Untranslated Regions (5' UTR)IBA 01/2022 - 01/2016
2	Therapeutic UsesIBA 01/2022 - 09/2019
2	Peptides (Polypeptides)IBA 01/2022 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2018
2	Memantine (Namenda)FDA Link 04/2020 - 10/2010
2	propylene diquat (PDQ(+))IBA 01/2020 - 11/2012
2	Indicators and Reagents (Reagents)IBA 01/2019 - 10/2017
2	Fragile X Mental Retardation ProteinIBA 01/2018 - 05/2013
1	RNA (Ribonucleic Acid)IBA 11/2023
1	PrebioticsIBA 01/2023
1	GuanineIBA 12/2022
1	CytosineIBA 12/2022
1	Cell Adhesion MoleculesIBA 02/2022
1	Liver X ReceptorsIBA 02/2022
1	AlbuminsIBA 02/2022
1	Amyloid (Amyloid Fibrils)IBA 02/2022
1	ApolipoproteinsIBA 02/2022
1	Cathepsin BIBA 02/2022
1	CholesterolIBA 02/2022
1	Retinoid X Receptors (Retinoid X Receptor)IBA 02/2022
1	Apolipoprotein C-II (ApoC2)IBA 02/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Butyric Acid (Butanoic Acid)IBA 01/2022
1	Succinic Acid (Succinate)IBA 01/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Levodopa (L Dopa)FDA LinkGeneric 11/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 11/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Caffeine (No Doz)FDA LinkGeneric 01/2021
1	IncretinsIBA 01/2021
1	hydroxide ionIBA 10/2020
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2020
1	Cytidine Diphosphate Choline (Citicoline)IBA 01/2020
1	Chemokine CCL5IBA 12/2019
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 12/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	AUT00063IBA 01/2019
1	Betahistine (Serc)IBA 12/2018
1	polyglycineIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018

Therapy/Procedure

19	Therapeutics 01/2023 - 10/2006
8	Hearing Aids (Hearing Aid) 01/2021 - 07/2011
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	CARE protocol 05/2022 - 01/2017
2	Aftercare (After-Treatment) 10/2020 - 04/2004
2	Relaxation Therapy (Relaxation Technique) 12/2018 - 12/2018
1	Dental Care 01/2019
1	Deep Brain Stimulation 01/2019
1	Contraindications 03/2018